Sun Pharma’s Q1FY23 Quarter Results
- 29 Jul 2022
- Sun Pharma reported 13% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended June (Q1FY23). On a year-on-year (YoY) basis, it witnessed a growth of 9%.
- Its expenses for the quarter were up by 10% QoQ and 14% YoY.
- The net profit increased by 43% on a YoY basis..
- The earnings per share (EPS) of Sun Pharma stood at 8.6 during Q1FY23..
Sun Pharma’s Financial Statements for Q1FY23:
(Rs, crores)
Total Income
Q1FY22
9,871
Q4FY22
9,560
Q1FY23
10,764
QoQ (%)
13%
YoY (%)
9%
(Rs, crores)
Total Expenses
Q1FY22
7,436
Q4FY22
7,700
Q1FY23
8,479
QoQ (%)
10%
YoY (%)
14%
(Rs, crores)
Profit before tax
Q1FY22
1,804
Q4FY22
-2,076
Q1FY23
2,285
QoQ (%)
-
YoY (%)
27%
(Rs, crores)
Tax
Q1FY22
396
Q4FY22
147
Q1FY23
189
QoQ (%)
29%
YoY (%)
-52%
(Rs, crores)
Profit after tax
Q1FY22
1,444
Q4FY22
-2,277
Q1FY23
2,061
QoQ (%)
-
YoY (%)
43%
(Rs, crores)
Earnings per share
Q1FY22
6.0
Q4FY22
-
Q1FY23
8.6
QoQ (%)
YoY (%)
| (Rs, crores) | Q1FY22 | Q4FY22 | Q1FY23 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
| Total Income | 9,871 | 9,560 | 10,764 | 13% | 9% |
| Total Expenses | 7,436 | 7,700 | 8,479 | 10% | 14% |
| Profit before tax | 1,804 | -2,076 | 2,285 | - | 27% |
| Tax | 396 | 147 | 189 | 29% | -52% |
| Profit after tax | 1,444 | -2,277 | 2,061 | - | 43% |
| Earnings per share | 6.0 | - | 8.6 |
Data Source: BSE, Company announcements
Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
